NASDAQ: VRCA
Verrica Pharmaceuticals Inc Stock Ownership - Who owns Verrica Pharmaceuticals?

Insider buying vs selling

Have Verrica Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Noah L. RosenbergCMO2026-08-182,030$4.92
$9.99kBuy
John J. KirbyCFO;Interim2026-08-185,000$4.93
$24.65kBuy
David ZawitzCOO2026-08-176,000$4.98
$29.88kBuy
Jayson RiegerCEO;Pres2026-08-175,000$4.91
$24.55kBuy
Noah L. RosenbergCMO2026-08-174,200$4.91
$20.62kBuy
Jayson RiegerCEO;Pres2026-08-1420,000$5.06
$101.20kBuy
David ZawitzChief Operating Officer2025-11-2510,000$4.24
$42.42kBuy
Noah L. RosenbergCMO2025-11-252,357$4.24
$10.00kBuy
John J. KirbyInterim CFO2025-11-253,536$4.24
$15.00kBuy
Paul B. ManningDirector2025-11-251,375,380$4.24
$5.83MBuy

1 of 2

VRCA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRCA insiders and whales buy or sell their stock.

VRCA Shareholders

What type of owners hold Verrica Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Paul B. Manning60.05%10,316,285$58.70MInsider
Perceptive Advisors LLC41.33%7,099,182$40.39MInsider
Bkb Growth Investments LLC19.49%3,348,372$19.05MInsider
Matt Davidson14.88%2,556,179$14.54MInsider
John A. Stalfort Iii10.91%1,873,800$10.66MInsider
Caligan Partners LP5.38%923,910$5.26MInsider
Sean Stalfort2.69%462,110$2.63MInsider
Ted White1.26%215,967$1.23MInsider
Jayson Rieger1.21%208,083$1.18MInsider
Christopher G. Hayes1.03%176,458$1.00MInsider

1 of 3

VRCA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRCA0.02%99.98%Net BuyingNet Buying
ATHE0.00%0.17%
CGTX0.02%28.70%Net Selling
YARW0.05%99.95%Net SellingNet Selling
KLRS0.01%99.99%Net Buying

Verrica Pharmaceuticals Stock Ownership FAQ

Who owns Verrica Pharmaceuticals?

Verrica Pharmaceuticals (NASDAQ: VRCA) is owned by 0.03% institutional shareholders, 160.38% Verrica Pharmaceuticals insiders, and 0.00% retail investors. Paul B. Manning is the largest individual Verrica Pharmaceuticals shareholder, owning 10.32M shares representing 60.05% of the company. Paul B. Manning's Verrica Pharmaceuticals shares are currently valued at $58.70M.

If you're new to stock investing, here's how to buy Verrica Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.